We then compared the dose-dependent effect of TMZ (0, 10, 25, 50, 75, and 100 μM) on the eight most TMZ-responsive GBM cell lines (group 1) after 3 days’ exposure to CSF. The gene discussed is CSF2; the disease is glioblastoma.